These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 26119306)

  • 61. Signalling Pathways Involved in Microglial Activation in Alzheimer's Disease and Potential Neuroprotective Role of Phytoconstituents.
    Ali MU; Anwar L; Ali MH; Iqubal MK; Iqubal A; Baboota S; Ali J
    CNS Neurol Disord Drug Targets; 2024; 23(7):819-840. PubMed ID: 36567300
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Recent Advances in ADAM17 Research: A Promising Target for Cancer and Inflammation.
    Moss ML; Minond D
    Mediators Inflamm; 2017; 2017():9673537. PubMed ID: 29230082
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Preventive Effects of Dairy Products on Dementia and the Underlying Mechanisms.
    Ano Y; Nakayama H
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966358
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Role of Chronic Inflammatory Bone and Joint Disorders in the Pathogenesis and Progression of Alzheimer's Disease.
    Culibrk RA; Hahn MS
    Front Aging Neurosci; 2020; 12():583884. PubMed ID: 33364931
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Neuroinflammation, microglia and implications for anti-inflammatory treatment in Alzheimer's disease.
    Krause DL; Müller N
    Int J Alzheimers Dis; 2010 Jun; 2010():. PubMed ID: 20798769
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A Flow-Extension Tethered Particle Motion Assay for Single-Molecule Proteolysis.
    Drabek AA; Loparo JJ; Blacklow SC
    Biochemistry; 2019 May; 58(20):2509-2518. PubMed ID: 30946563
    [TBL] [Abstract][Full Text] [Related]  

  • 67. How membrane asymmetry regulates ADAM17 sheddase function.
    Sommer A; Bhakdi S; Reiss K
    Cell Cycle; 2016 Nov; 15(22):2995-2996. PubMed ID: 27463373
    [No Abstract]   [Full Text] [Related]  

  • 68. [Old and new inflammation and infection hypotheses of Alzheimer's disease: focus on Microglia-aging for chronic neuroinflammation].
    Wu Z; Nakanishi H
    Nihon Yakurigaku Zasshi; 2017; 150(3):141-147. PubMed ID: 28890476
    [No Abstract]   [Full Text] [Related]  

  • 69. MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer's disease.
    Baranger K; Marchalant Y; Bonnet AE; Crouzin N; Carrete A; Paumier JM; Py NA; Bernard A; Bauer C; Charrat E; Moschke K; Seiki M; Vignes M; Lichtenthaler SF; Checler F; Khrestchatisky M; Rivera S
    Cell Mol Life Sci; 2016 Jan; 73(1):217-36. PubMed ID: 26202697
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease.
    Wang WY; Tan MS; Yu JT; Tan L
    Ann Transl Med; 2015 Jun; 3(10):136. PubMed ID: 26207229
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Role of RAGE in Alzheimer's Disease.
    Cai Z; Liu N; Wang C; Qin B; Zhou Y; Xiao M; Chang L; Yan LJ; Zhao B
    Cell Mol Neurobiol; 2016 May; 36(4):483-95. PubMed ID: 26175217
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Increased neuronal PreP activity reduces Aβ accumulation, attenuates neuroinflammation and improves mitochondrial and synaptic function in Alzheimer disease's mouse model.
    Fang D; Wang Y; Zhang Z; Du H; Yan S; Sun Q; Zhong C; Wu L; Vangavaragu JR; Yan S; Hu G; Guo L; Rabinowitz M; Glaser E; Arancio O; Sosunov AA; McKhann GM; Chen JX; Yan SS
    Hum Mol Genet; 2015 Sep; 24(18):5198-210. PubMed ID: 26123488
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Phospholipid transfer protein (PLTP) deficiency accelerates memory dysfunction through altering amyloid precursor protein (APP) processing in a mouse model of Alzheimer's disease.
    Tong Y; Sun Y; Tian X; Zhou T; Wang H; Zhang T; Zhan R; Zhao L; Kuerban B; Li Z; Wang Q; Jin Y; Fan D; Guo X; Han H; Qin S; Chui D
    Hum Mol Genet; 2015 Oct; 24(19):5388-403. PubMed ID: 26160914
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Loss of neprilysin alters protein expression in the brain of Alzheimer's disease model mice.
    Nilsson P; Loganathan K; Sekiguchi M; Winblad B; Iwata N; Saido TC; Tjernberg LO
    Proteomics; 2015 Oct; 15(19):3349-55. PubMed ID: 26194619
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pre-analytical and analytical factors influencing Alzheimer's disease cerebrospinal fluid biomarker variability.
    Fourier A; Portelius E; Zetterberg H; Blennow K; Quadrio I; Perret-Liaudet A
    Clin Chim Acta; 2015 Sep; 449():9-15. PubMed ID: 26141614
    [TBL] [Abstract][Full Text] [Related]  

  • 76. CYP46A1 inhibition, brain cholesterol accumulation and neurodegeneration pave the way for Alzheimer's disease.
    Djelti F; Braudeau J; Hudry E; Dhenain M; Varin J; Bièche I; Marquer C; Chali F; Ayciriex S; Auzeil N; Alves S; Langui D; Potier MC; Laprevote O; Vidaud M; Duyckaerts C; Miles R; Aubourg P; Cartier N
    Brain; 2015 Aug; 138(Pt 8):2383-98. PubMed ID: 26141492
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Expression of β-site APP-cleaving enzyme 1 in the hippocampal tissue of an insulin-resistant rat model of Alzheimer's disease.
    Li S; Wang N; Lou J; Zhang X
    Exp Ther Med; 2015 Jun; 9(6):2389-2393. PubMed ID: 26136993
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Visualization of regional tau deposits using (3)H-THK5117 in Alzheimer brain tissue.
    Lemoine L; Saint-Aubert L; Marutle A; Antoni G; Eriksson JP; Ghetti B; Okamura N; Nennesmo I; Gillberg PG; Nordberg A
    Acta Neuropathol Commun; 2015 Jul; 3():40. PubMed ID: 26134112
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Effects of stem cell transplantation on cognitive decline in animal models of Alzheimer's disease: A systematic review and meta-analysis.
    Wang Z; Peng W; Zhang C; Sheng C; Huang W; Wang Y; Fan R
    Sci Rep; 2015 Jul; 5():12134. PubMed ID: 26159750
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice.
    Skerrett R; Pellegrino MP; Casali BT; Taraboanta L; Landreth GE
    J Biol Chem; 2015 Aug; 290(35):21591-602. PubMed ID: 26163517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.